Mannose targeting of poly(lactic-co-glycolic acid): a promising approach for improving sublingual allergen-specific immunotherapy

Navideh Haghnavaz Mohammad Ali Rezaee Safoora Pordel Saeideh Sadat Shobeiri Mohammad reza Dashti Bahareh Ansari Motahare Khorrami Malihe Moghadam Mojtaba Sankian a Immunology Research Center,Medical School,Mashhad University of Medical Sciences,Mashhad,Iranb Department of Medical Laboratory Sciences,Faculty of Paramedical,Kurdistan University of Medical Sciences,Sanandaj,Iranc Cellular and molecular research center,Sabzevar University of Medical Sciences,Sabzevar,Irand Kashmar School of Medical Sciences,Mashhad University of Medical Sciences,Mashhad,Iran
DOI: https://doi.org/10.1080/08923973.2024.2410291
IF: 3.712
2024-10-09
Immunopharmacology and Immunotoxicology
Abstract:Objective One of the most effective treatments for allergic respiratory diseases is allergen-specific sublingual immunotherapy (SLIT). While, mannose targeting has been applied in various immunostimulatory approaches, but it has not been investigated in sublingual allergen-specific immunosuppressive treatment. This study assesses mannose targeting for the ovalbumin (Ova) loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles(NPs).
pharmacology & pharmacy,immunology,toxicology
What problem does this paper attempt to address?